Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
These 45 exoplanets may be the best places to search for alien life - 2Instructions to Pick the Right Dental Embed Trained professional: An Exhaustive Aide
- 3Vote in favor of Your #1 4\u00d74 SUVs
- 44 Electric Vehicle Brands: Execution, Unwavering quality, and Development
- 5EU waters down plans to end new petrol and diesel car sales by 2035
- The Most Enrapturing Authentic Milestones to Visit
- Netanyahu leads meeting on West Bank riots, Katz defends axing administrative detention for Jews
- Bennu asteroid samples provide clues about solar system origins and 'space gum'
- Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
- Rescuers again fail to free whale stranded on Germany's Baltic coast
- A coup too far: Why Benin's rebel soldiers failed where others in the region succeeded
- 6 Modest and Strong Tire Brands
- Relish the World: Notable Caf\u00e9s You Really want to Attempt
- Tributes pour in for MIT professor Nuno Loureiro amid unresolved shooting case
